The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) perspective on cardiovascular Polypill: A multidimensional concept

Cardiol J. 2016;23(5):515-517. doi: 10.5603/CJ.2016.0074.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cardiovascular Diseases / drug therapy*
  • Drug Approval / organization & administration*
  • Europe
  • Humans
  • Polypharmacy*
  • United States
  • United States Food and Drug Administration*